HEM/ONC Education Center

Welcome to the Blood CME Center’s Hematology and Oncology Education Center, developed by experts in the field of hematologic malignancies to deliver high-quality, clinically practical education to clinicians dedicated to helping patients fight blood cancers. Exclusive interactive CME educational activities include vodcasts, Clinical Insightstm, and CEnowtm personalized modular learning forums.
 
 
Hematologic Malignancy PeerPaths™
Your Personalized Modular Learning Forum

Welcome to the Blood CME Center’s Hematologic Malignancy PeerPathstm! This novel online resource provides a customized method of offering clinicians disease-specific learning paths to follow. Choose your preferred disease track and engage in several relevant programs that are designed to provide a focused and complete treatment of the subject matter. The PeerPathstm personalized modular learning forum is preferred by clinicians because it provides a personalized learning path that reflects your interests and educational goals in a variety of learning modules.
image
“Improving Outcomes in Hematologic Malignancies via Individualized Therapy”
Credits: 0.5 CME / 0.5 CNE Expires: 8/2012
According to the World Health Organization, there are more than 30 unique types of lymphomas. In this CME activity, blood oncology expert Charles M. Farber, MD, PhD, discusses the different types of hematologic malignancies and how clinicians should evolve therapeutic approaches based on factors such as tumor classification and patient response.
image

image
“Clinical Decisions in Multiple Myeloma: Utilizing Novel Agents to Improve Survival Outcomes”
Credits: 0.5 CME / 0.6 CNE Expires: 4/2012
Novel combination regimens have had a profound effect on the treatment of patients with multiple myeloma. In this interactive learning activity, Charles M. Farber, MD, PhD, draws on his clinical experience to discuss current treatment strategies for treating multiple myeloma patients, the clinical benefits of using novel agents in treatment regimens, and the place for novel agents in transplantation protocols.
image

image
“Evaluating the Role of Maintenance Therapy in the Management of Multiple Myeloma”
Credits: 1.0 CME / 1.0 CNE Expires: 4/2012
Multiple myeloma remains an incurable disease for the majority of patients. The goal of maintenance therapy is to help patients achieve and maintain a durable remission. In this learning activity, Ashraf Badros, MD, discusses the role of maintenance therapy when treating multiple myeloma and examines recommended treatment strategies for various patient cohorts.
image

image
“Developing Individualized Treatment Strategies Based on Biology and Physiology of the Multiple Myeloma Patient”
Credits: 1.0 CME / 1.0 CNE Expires: 3/2012
Multiple myeloma is an incurable hematologic malignancy characterized by a highly variable duration of response and long-term outcomes, with treatment relapse remaining a key issue. In this learning activity, blood oncology expert Sagar Lonial, MD, offers his expertise on individualized treatment strategies for multiple myeloma patients and compares clinical evidence for utilizing novel agent-based regimens in different patient cohorts. This activity also features additional commentary from Charise Gleason, MSN, NP-C, AOCNP.
image


 
Link to PIM Link to CMH Link to PIM Link to CMH Link to PIM Link to CMH Link to CMH Link to PIM Link to CMH Link to CMH register Eval Subscribe Hemophilia Bleeding Disorders Journal Club RSS Feed Hemophilia/Bleeding Disorders Journal Club Home